Concepedia

Xuyang Lv

XL

Statistics

Publications

2

Citations

41

H-Index

2

Active since

2019

Affiliations

Zhejiang Chinese Medical University(Current)

Xuyang Lv is an author at Zhejiang Chinese Medical University specializing in oncology, medicine, and noncoding rna in cancer.

Publications per year

2019–2021

2

Publications

2

<i>FoxD2-AS1</i>is a prognostic factor in glioma and promotes temozolomide resistance in a O<sup>6</sup>-methylguanine-DNA methyltransferase-dependent manner

Wenbing Shangguan, Xuyang Lv, Nan Tian · Korean Journal of Physiology and Pharmacology · 2019 · 22 citations · Full text

, , +17

Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation

Xuyang Lv, Jiangchuan Sun, Linfeng Hu et al. · Aging · 2021 · 19 citations · Full text

, , +15

1–2 of 2